Sanofi
SNY
S$61.61
Share price
0.50%
Change (1 day)
-2.89%
Change (1 year)
Categories
Sanofi is a French pharmaceutical company created in 2004 by the merger of Sanofi-Synthélabo and Aventis. With sales of EUR 36.1 billion in 2019 and more than 100,000 employees worldwide, Sanofi is one of the largest pharmaceutical companies in the world in terms of sales.
Market capitalization of Sanofi (SNY)
Market cap: S$150.03 Billion
As of June 2025 Sanofi has a market cap of S$150.03 Billion. This makes Sanofi the world's 152th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Sanofi from 2002 to 2025
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2025 | S$150.03 B | -9.65% |
| 2024 | S$166.06 B | 0.82% |
| 2023 | S$164.71 B | 1.15% |
| 2022 | S$162.84 B | -4.11% |
| 2021 | S$169.82 B | 5.56% |
| 2020 | S$160.88 B | -5.19% |
| 2019 | S$169.69 B | 15.24% |
| 2018 | S$147.25 B | 2% |
| 2017 | S$144.37 B | -4.67% |
| 2016 | S$151.43 B | -4.58% |
| 2015 | S$158.71 B | -1.05% |
| 2014 | S$160.39 B | -10.24% |
| 2013 | S$178.68 B | 15.41% |
| 2012 | S$154.81 B | 20.43% |
| 2011 | S$128.55 B | 19.62% |
| 2010 | S$107.46 B | -26.4% |
| 2009 | S$146.02 B | 20.74% |
| 2008 | S$120.93 B | -32.43% |
| 2007 | S$178.98 B | -7.02% |
| 2006 | S$192.48 B | -6.04% |
| 2005 | S$204.85 B | 11.07% |
| 2004 | S$184.43 B | 96.2% |
| 2003 | S$94.00 B | 21.67% |
| 2002 | S$77.26 B |
End of Day market cap according to different sources
On Jun 20th, 2025 the market cap of Sanofi was reported to be:
S$155.65 Billion
S$150.03 Billion
Market capitalization for similar companies or competitors
| Name | Marketcap | Market cap differencediff. | Country |
|---|---|---|---|
 Merck MRK | S$255.57 B | 70.34% | 🇺🇸 USA |
 Pfizer PFE | S$175.44 B | 16.93% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | S$122.77 B | -18.17% | 🇺🇸 USA |
 Novartis NVS | S$295.02 B | 96.63% | 🇨🇭 Switzerland |
 GlaxoSmithKline GSK | S$99.98 B | -33.36% | 🇬🇧 UK |
 Teva Pharmaceutical Industries TEVA | S$25.54 B | -82.97% | 🇮🇱 Israel |
 Johnson & Johnson JNJ | S$463.98 B | 209.25% | 🇺🇸 USA |
 Eli Lilly LLY | S$881.52 B | 487.54% | 🇺🇸 USA |
 Novo Nordisk NVO | S$428.45 B | 185.56% | 🇩🇰 Denmark |
 Abbott Laboratories ABT | S$297.88 B | 98.54% | 🇺🇸 USA |